NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 243 filers reported holding NEOGENOMICS INC in Q4 2022. The put-call ratio across all filers is 0.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $140,000 | +4.5% | 16,270 | -0.8% | 0.00% | – |
| Q2 2022 | $134,000 | -32.3% | 16,404 | +0.7% | 0.00% | – |
| Q1 2022 | $198,000 | -65.3% | 16,293 | -2.8% | 0.00% | -100.0% |
| Q4 2021 | $571,000 | -15.8% | 16,758 | +19.2% | 0.00% | -50.0% |
| Q3 2021 | $678,000 | +8.7% | 14,057 | +1.8% | 0.00% | 0.0% |
| Q2 2021 | $624,000 | -3.1% | 13,812 | +3.4% | 0.00% | 0.0% |
| Q1 2021 | $644,000 | -13.3% | 13,355 | -3.3% | 0.00% | 0.0% |
| Q4 2020 | $743,000 | +42.6% | 13,809 | -2.2% | 0.00% | 0.0% |
| Q3 2020 | $521,000 | -8.0% | 14,119 | -22.8% | 0.00% | 0.0% |
| Q2 2020 | $566,000 | +84.4% | 18,281 | +64.4% | 0.00% | +100.0% |
| Q1 2020 | $307,000 | -5.8% | 11,122 | -0.3% | 0.00% | 0.0% |
| Q4 2019 | $326,000 | +54.5% | 11,158 | +1.3% | 0.00% | 0.0% |
| Q3 2019 | $211,000 | -10.6% | 11,018 | +2.5% | 0.00% | 0.0% |
| Q2 2019 | $236,000 | – | 10,753 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 2,023,355 | $91,395,000 | 37.83% |
| Blue Water Life Science Advisors, LP | 702,222 | $31,719,000 | 11.94% |
| Burrage Capital Management LLC | 147,921 | $6,682,000 | 6.70% |
| PERKINS CAPITAL MANAGEMENT INC | 158,300 | $7,150,000 | 4.06% |
| First Light Asset Management, LLC | 1,148,945 | $51,898,000 | 3.11% |
| Soleus Capital Management, L.P. | 352,007 | $15,900,000 | 2.44% |
| Ranger Investment Management | 832,286 | $37,594,000 | 1.96% |
| Avidity Partners Management LP | 1,367,000 | $61,747,000 | 1.67% |
| Bullseye Asset Management LLC | 108,672 | $4,909,000 | 1.65% |
| Tygh Capital Management, Inc. | 255,541 | $11,543,000 | 1.57% |